Last $21.09 USD
Change Today +0.20 / 0.96%
Volume 675.2K
BMR On Other Exchanges
Symbol
Exchange
New York
Frankfurt
As of 8:04 PM 11/21/14 All times are local (Market data is delayed by at least 15 minutes).

biomed realty trust inc (BMR) Key Developments

BioMed Realty Trust Inc. and Broad Institute of MIT and Harvard Form Strategic Partnership to Promote Innovation and Collaboration Within the Life Science Industry

BioMed Realty Trust Inc. and the Broad Institute of MIT and Harvard announced a strategic partnership to foster innovation and promote relationships between academia and the life science industry. This partnership brings together one of the most innovative research organizations in the world with the leading provider of real estate to the life science industry. BioMed Realty, through its strategic investment group, BioMed Ventures, will work with the Broad Institute to engage the biomedical community through several events designed to bring together thought leaders from academia, biotech and pharmaceutical companies and the investment community to stimulate conversations across their networks.

MPM Capital Signs Lease Agreement with BioMed Realty Trust

MPM Capital has signed a lease for about 14,500 square feet in a new office building at 450 Kendall St. That's about a quarter of the space in the building, which is touted by owner BioMed Realty Trust as the first speculative office building constructed in Cambridge since the dot-com bubble burst in 2001. It's also about 25% bigger than MPM's current location in the John Hancock Tower, and includes space on the fourth and fifth floors with outdoor terraces overlooking Broad Canal. The firm plans to move in April.

Biomed Realty Trust Inc. Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2014; Provides Earnings Guidance for the full year 2014 and 2015

BioMed Realty Trust Inc. announced unaudited consolidated earnings results for the third quarter and nine months ended September 30, 2014. For the quarter, the company’s total revenues were $168,916,000 compared to $159,232,000 a year ago. Income from operations was $36,310,000 compared to $32,805,000 a year ago. Net income was $16,976,000 compared to $4,136,000 a year ago. Net income attributable to the company was $15,960,000 compared to $4,247,000 a year ago. Net income available to common stockholders was $15,960,000 compared to $4,247,000 a year ago. Income from continuing operations per share available to common stockholders basic and diluted earnings per share was $0.08 compared to $0.02 a year ago. Diluted FFO available to common shares and units was $83,695,000 or $0.40 per share compared to $67,586,000 or $0.33 per share a year ago. AFFO available to common shares and units was $72,692,000 or $0.35 per share compared to $60,719,000 or $0.29 per share a year ago. For the nine months, the company’s total revenues were $508,953,000 compared to $479,321,000 a year ago. Income from operations was $118,274,000 compared to $121,299,000 a year ago. Net income was $56,841,000 compared to $36,633,000 a year ago. Net income attributable to the company was $53,429,000 compared to $36,365,000 a year ago. Net income available to common stockholders was $53,429,000 compared to $27,441,000 a year ago. Income from continuing operations per share available to common stockholders basic and diluted earnings per share was $0.27 compared to $0.15 a year ago. Diluted FFO available to common shares and units was $250,454,000 or $1.20 per share compared to $219,434,000 or $1.13 per share a year ago. AFFO available to common shares and units was $219,524,000 or $1.05 per share compared to $216,095,000 or $1.13 per share a year ago. For the full year 2014, projected net income per diluted share available to common stockholders is expected to be $0.31. Projected FFO per diluted share was $1.57. Projected CFFO per diluted share was $1.58. The company's 2014 FFO and CFFO estimates reflect the company's year-to-date operating results and include other revenue and income items aggregating $0.18 per diluted share. These items primarily include lease termination fees, construction loan income and net investment gains. Excluding the impact of these items, Projected CFFO per diluted share for 2014 would be $1.40 per diluted share Full-year 2014 guidance implies fourth quarter estimates of FFO and CFFO of $0.37 per diluted share which includes the effects of the 50 Hampshire and AVEO Pharmaceuticals lease terminations and which have the net effect of increasing the company's 2014 fourth quarter estimates of FFO and CFFO by approximately $0.01 per diluted share. For the year 2015, projected net income per diluted share available to common stockholders is expected to be between $0.21 to $0.31. Projected FFO and CFFO per diluted share is expected to be between $1.45 to $1.55. Rental revenues are expected to be between $490,000 to $530,000.

BioMed Realty Trust Inc. to Report Q3, 2014 Results on Oct 29, 2014

BioMed Realty Trust Inc. announced that they will report Q3, 2014 results at 5:00 PM, Eastern Standard Time on Oct 29, 2014

BioMed Realty Trust Inc., Q3 2014 Earnings Call, Oct 30, 2014

BioMed Realty Trust Inc., Q3 2014 Earnings Call, Oct 30, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BMR:US $21.09 USD +0.20

BMR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Alexandria Real Estate Equities Inc $82.20 USD +0.62
American Campus Communities Inc $39.36 USD +0.71
Douglas Emmett Inc $27.08 USD +0.24
Equity LifeStyle Properties Inc $48.04 USD +0.50
Home Properties Inc $63.85 USD +0.81
View Industry Companies
 

Industry Analysis

BMR

Industry Average

Valuation BMR Industry Range
Price/Earnings 66.9x
Price/Sales 6.3x
Price/Book 1.4x
Price/Cash Flow 13.3x
TEV/Sales 1.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIOMED REALTY TRUST INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.